Biocept Launches Liquid Biopsy Test for NRAS Mutations
Expands commercial offering to 15 clinically actionable biomarker tests, including key validated alterations listed in the NCCN Guidelines® for metastatic melanoma and colorectal cancer
SAN DIEGO, Sept. 5, 2017 -- (Healthcare Sales & Marketing Netwo... Diagnostics, Oncology, Product Launch Biocept, liquid biopsy, Target Selector, NRAS
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Marketing | Melanoma | Pharmaceuticals | Skin Cancer